Skip to main content

Advertisement

Fig. 3 | EJNMMI Research

Fig. 3

From: 18F-FDG and 11C-4DST PET/CT for evaluating response to platinum-based doublet chemotherapy in advanced non-small cell lung cancer: a prospective study

Fig. 3

Kaplan-Meier analysis for overall survival (OS) in patients with advanced non-small-cell lung cancer treated with platinum-based doublet chemotherapy. (PT-DC). a OS according to metabolic tumor volume (MTV) of baseline FDG. b OS according to total lesion glycolysis (TLG) of baseline FDG. c PFS according to MTV of baseline 4DST

Back to article page